Arrowhead Research Corp (NASDAQ:ARWR)

CAPS Rating: 3 out of 5

A development stage nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy.

Recs

1
Player Avatar alopex (98.92) Submitted: 7/7/2007 3:58:13 PM : Underperform Start Price: $51.70 ARWR Score: +32.28

Wild mix of activities all aimed at attracting uncanny investors through broad band buzz-word bingo. Financials reflect that none of these areas are commercialized and probably will never be. Try to compete in semiconductor + pharma + nano-technology with 60 R&D staffers against the world leaders. The only hope is to strike some luck in patent filing and sue the big ones NTP-style (see the RIMM patent suits).

Featured Broker Partners


Advertisement